Article Details

Durable Long-term Results With Dolutegravir for HIV Suppression | MedPage Today

Retrieved on: 2022-07-31 18:33:07

Tags for this article:

Click the tags to see associated articles and topics

Durable Long-term Results With Dolutegravir for HIV Suppression | MedPage Today. View article details on hiswai:

Excerpt

After 144 weeks of treatment, 88% of 93 patients enrolled in the SIMPL'HIV study who were taking dolutegravir (Tivicay) plus emtricitabine (Emtriva) ...

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up